On June 8, 2026, kneat.com, Inc., a Toronto-listed, Limerick, Ireland-founded digital validation and quality process automation software company serving life sciences and other highly regulated industries through its Kneat Gx platform, announced that it had entered into a definitive arrangement agreement with an affiliate of Thoma Bravo, L.P. pursuant to which Thoma Bravo will acquire all of the issued and outstanding common shares of the company for $6.50 per share in cash. The consideration values Kneat at an aggregate total equity value of approximately $650 million on a fully diluted, in-the-money, treasury-stock method basis and inclusive of rollover shares. The purchase price represents a 40 percent premium over the closing price on May 8, 2026, the last trading day before Kneat announced its strategic review, and a 20 percent premium over the closing price on the trading day immediately preceding announcement. Thoma Bravo and certain existing director and management shareholders may agree to a rollover of a portion of their equity into shares of the purchaser or an affiliate at a value equal to the purchase price, with the specific terms (including which shareholders may be rolling shareholders and how many shares may be rolled over) to be negotiated. The Kneat board unanimously approved the arrangement agreement following the unanimous recommendation of the Special Committee. The arrangement agreement includes a break fee of approximately $22.6 million payable in certain circumstances. The transaction will be implemented by way of a court-approved plan of arrangement and is expected to close in the third quarter of 2026, subject to shareholder, court and regulatory approvals.